The TMPRSS2:ERG fusion product can be found in 20% of prostatic intraepithelial neoplasia (PIN) adjacent to fusion positive cancer tissue but not in benign prostate tissue specimens or proliferative inflammatory atrophy (PIA) [23]. Here, ERG is linked to prostate intraepithelial neoplasia.